Lupin spurted 10.75 per cent to Rs 644.40 after its unit Lupin Pharmaceuticals received tentative approval from US Food and Drug Administration (FDA) for selling ramipril capsules, used for treating cardiovascular diseases and high blood pressure.

<tr><td><p class='TableClas'></p><P class='TableClas'> <DIV CLASS=rightDiv><script language="JavaScript">
		google_ad_client = 'businessstandard';
		//google_ad_client = 'ca-businessstandard_js';
		google_ad_width = 200;
		google_ad_height = 200;
		google_ad_format = "200x200_as";
		google_ad_type = "text";
		google_ad_channel = "";
		//google_color_border = "FFFFFF";
		google_color_border = "F7F7F7";
		//google_color_bg = "FFFFFF";
		google_color_bg = "ffffff";
		//google_color_link = "639ACE";
		google_color_link = "0253B7";
		google_color_text = "000000";
		google_color_url = "D63431";
		//google_skip = adsenseSkip;
		</script> 
		<script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
		</script> </DIV><p class='TableClas'>Lupin has revealed that it is looking for acquisitions in the United States and emerging markets to expand its overseas operations. 
</p><p class='TableClas'>The stock witnessed total volumes of 4.35 lakh shares as compared to the two-week average volumes of 60,158 shares. It hit an intra-day high of Rs 661 and a low of Rs 575. The stock has appreciated over 28 per cent in the last one month. </P></p></table>


Lupin soars on receiving FDA nod for drug sale

Stay ahead of the market with insights on buzzing stocks and actionable information to guide your investment decisions

Lupin soars on receiving FDA nod for drug sale

DALAL STREET SPIKES

More From This Section

Idea shares fall after Q3 earnings disappoint

BofA-Merrill raises Indiabulls to 'buy', stock gains

Suzlon stocks jump 17% on CDR approval

Maruti Suzuki rallies as Q3 profit beats analyst's estimates

Explore News